| (Philadelphia, PA) – Dr. Larry Kricka,
Director of General Chemistry at the Hospital of the University
of Pennsylvania (HUP), has been named the winner of the
2006 Edwin F. Ullman Award. The award recognizes an individual (or
individuals) for contributions that advance the technology of clinical
laboratory sciences through the creation of new technologies and
analytical methods. In July, Dr. Kricka will be presented with the
Ullman Award at the American Association for Clinical Chemistry’s
(AACC) annual meeting in Chicago.
Although the award is given for a scientist’s body of work,
two of Kricka’s efforts, in particular, have had a profound
benefical effect on the field of laboratory medicine. The first
is his application of chemiluminescence and bioluminescence to clinical
analysis. He was instrumental in the development of two of the three
major chemiluminescent technologies currently used in routine testing,
including an enhanced luminescence system for peroxidase labels
and the 1,2-dioxetane substrate, now widely used to detect alkaline
phosphatase labels and other hydrolytic enzymes. He has also played
an important role in adapting chemiluminescent and bioluminescent
assays to point-of-care testing.
His second defining work, in collaboration with Dr. Peter
Wilding, is with miniaturization – specifically,
analytical microchips. Dr. Kricka played a critical role in the
development of micro-fabricated clinical analysis devices and devices
that isolate cells, analyze DNA, test for fertility, assist in vitro
fertilization, immunoassay testing for drugs and hormones, and integrate
tests for malignancy. These miniaturization techniques have pioneered
a field of testing based in silicon-glass and plastic micro-structures
and resulted in the first demonstration of numerous analytically
useful processes in microchips, including immunoassay, assessment
of sperm motility, and DNA amplification. Today many laboratories
and companies have research and development programs based on Kricka’s
discoveries.
“What we wanted to do was miniaturize and simplify testing,”
said Kricka. “These chips can be used at the point-of-care
in a doctor’s office or in the field for bio-terrorism tests,
which is one of the main ways they are being used. There are a lot
of potential uses for them.”
Although Dr. Kricka has received many awards during his 19 years
at HUP, this one holds special significance because someone else
nominated him, anonymously. “I am very pleased to win,”
he said. “I didn’t even know I was nominated for it.
It was a total surprise. Actually, the president of the AACC called
me and I thought he was calling to ask me to do some work for the
AACC. Instead he was calling me to tell me I won the prize.”
Along with an extensive patent portfolio, Kricka is also one of
the founders of the Micro and Nanotechnology Center established
within the Department of Pathology and Laboratory Medicine at HUP.
The award, sponsored by Dade Behring Inc., is named in honor of
Edwin F. Ullman, a pioneer in immunoassay technology who has received
more than 150 U.S. patents.
###
PENN Medicine is a $2.7 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn’s School of Medicine is ranked #2 in the nation
for receipt of NIH research funds; and ranked #4 in the nation in
U.S. News & World Report’s most recent ranking of top
research-oriented medical schools. Supporting 1,400 fulltime faculty
and 700 students, the School of Medicine is recognized worldwide
for its superior education and training of the next generation of
physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System comprises: its
flagship hospital, the Hospital of the University of Pennsylvania,
consistently rated one of the nation’s “Honor Roll”
hospitals by U.S. News & World Report; Pennsylvania Hospital,
the nation's first hospital; Penn Presbyterian Medical Center; a
faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home health care and hospice.
|